WO2026093452A1 - Composition à base de lait comprenant un gos permettant d'augmenter l'absorption de fer - Google Patents

Composition à base de lait comprenant un gos permettant d'augmenter l'absorption de fer

Info

Publication number
WO2026093452A1
WO2026093452A1 PCT/EP2025/081410 EP2025081410W WO2026093452A1 WO 2026093452 A1 WO2026093452 A1 WO 2026093452A1 EP 2025081410 W EP2025081410 W EP 2025081410W WO 2026093452 A1 WO2026093452 A1 WO 2026093452A1
Authority
WO
WIPO (PCT)
Prior art keywords
iron
milk
composition
galactooligosaccharide
based composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/EP2025/081410
Other languages
English (en)
Inventor
Magalie Sabatier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of WO2026093452A1 publication Critical patent/WO2026093452A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1206Lactose hydrolysing enzymes, e.g. lactase, beta-galactosidase
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1522Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/15Inorganic Compounds
    • A23V2250/156Mineral combination
    • A23V2250/1592Iron
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/28Oligosaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/28Oligosaccharides
    • A23V2250/284Oligosaccharides, non digestible

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)

Abstract

L'invention concerne des procédés et des compositions qui augmentent l'absorption du fer, par exemple en augmentant la capacité d'absorption du fer et/ou en augmentant la biodisponibilité du fer. L'invention concerne un procédé d'augmentation de l'absorption du fer, de préférence présent naturellement dans un aliment, un repas ou un régime alimentaire à base de plantes, comprenant l'administration à un individu qui en a besoin d'un galactooligosaccharide (GOS) de la composition à base de lait, de préférence une composition à base de lait à faible teneur en lactose et faible teneur en sucre comprenant du galactooligosaccharide (GOS). L'individu, auquel la composition à base de lait est administrée, peut être choisi parmi des adultes ; des personnes âgées ; des femmes enceintes ou allaitantes ; des femmes ménopausées ou periménopausées, des nourrissons ; des enfants ; et des sujets suivant un régime végétarien, un régime flexitarien, un régime végétalien ou tout type de régime à base de plantes.
PCT/EP2025/081410 2024-10-31 2025-10-30 Composition à base de lait comprenant un gos permettant d'augmenter l'absorption de fer Pending WO2026093452A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202463714267P 2024-10-31 2024-10-31
US63/714,267 2024-10-31

Publications (1)

Publication Number Publication Date
WO2026093452A1 true WO2026093452A1 (fr) 2026-05-07

Family

ID=97598778

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2025/081410 Pending WO2026093452A1 (fr) 2024-10-31 2025-10-30 Composition à base de lait comprenant un gos permettant d'augmenter l'absorption de fer

Country Status (1)

Country Link
WO (1) WO2026093452A1 (fr)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140087021A1 (en) 2011-05-24 2014-03-27 Nestec S.A Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
US20160044945A1 (en) * 2013-03-22 2016-02-18 N.V. Nutricia Fermented nutrition high in lactose with increased iron bioavailability
US20160050960A1 (en) * 2013-03-22 2016-02-25 N.V. Nutricia Fermented nutrition with non-digestible oligosaccharides with increased iron bioavailability
US10124016B2 (en) 2008-06-13 2018-11-13 N.V. Nutricia Immune system stimulating nutrition
EP3624594A1 (fr) 2017-05-15 2020-03-25 Novozymes A/S Produits laitiers comprenant de grandes quantités de galacto-oligosaccharides (gos) et leur production
CN111466443A (zh) * 2020-04-14 2020-07-31 周赛新 一种儿童成长营养奶粉
WO2022241163A1 (fr) 2021-05-13 2022-11-17 Bcd Bioscience, Inc. Procédés d'utilisation de compositions d'oligosaccharides pour moduler le microbiote et leurs produits métaboliques, et en tant qu'agents thérapeutiques pour des applications de santé
US11529364B2 (en) 2014-12-08 2022-12-20 Glycom A/S Synthetic composition for treating metabolic disorders
WO2023057540A1 (fr) 2021-10-07 2023-04-13 Société des Produits Nestlé S.A. Procédé de préparation de compositions alimentaires traitées par voie enzymatique avec gos et faible teneur en lactose et compositions alimentaires correspondantes
CN117546915A (zh) * 2023-12-12 2024-02-13 陕西科技大学 一种功能性绵羊奶粉及其制备方法

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10124016B2 (en) 2008-06-13 2018-11-13 N.V. Nutricia Immune system stimulating nutrition
US20140087021A1 (en) 2011-05-24 2014-03-27 Nestec S.A Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
US20160044945A1 (en) * 2013-03-22 2016-02-18 N.V. Nutricia Fermented nutrition high in lactose with increased iron bioavailability
US20160050960A1 (en) * 2013-03-22 2016-02-25 N.V. Nutricia Fermented nutrition with non-digestible oligosaccharides with increased iron bioavailability
US11529364B2 (en) 2014-12-08 2022-12-20 Glycom A/S Synthetic composition for treating metabolic disorders
EP3624594A1 (fr) 2017-05-15 2020-03-25 Novozymes A/S Produits laitiers comprenant de grandes quantités de galacto-oligosaccharides (gos) et leur production
CN111466443A (zh) * 2020-04-14 2020-07-31 周赛新 一种儿童成长营养奶粉
WO2022241163A1 (fr) 2021-05-13 2022-11-17 Bcd Bioscience, Inc. Procédés d'utilisation de compositions d'oligosaccharides pour moduler le microbiote et leurs produits métaboliques, et en tant qu'agents thérapeutiques pour des applications de santé
WO2023057540A1 (fr) 2021-10-07 2023-04-13 Société des Produits Nestlé S.A. Procédé de préparation de compositions alimentaires traitées par voie enzymatique avec gos et faible teneur en lactose et compositions alimentaires correspondantes
CN117546915A (zh) * 2023-12-12 2024-02-13 陕西科技大学 一种功能性绵羊奶粉及其制备方法

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ALY ESMAT ET AL: "Supplementation of infant formulas with recombinant human lactoferrin and/or galactooligosaccharides increases iron bioaccessibility as measured by ferritin formed in Caco-2 cell model", FOOD RESEARCH INTERNATIONAL, ELSEVIER, AMSTERDAM , NL, vol. 89, 24 August 2016 (2016-08-24), pages 1048 - 1055, XP029816281, ISSN: 0963-9969, DOI: 10.1016/J.FOODRES.2016.08.030 *
CHRISTIDES TATIANA ET AL: "In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics", EUROPEAN JOURNAL OF NUTRITION, vol. 57, no. 2, 9 December 2016 (2016-12-09), DE, pages 669 - 678, XP093354666, ISSN: 1436-6207, DOI: 10.1007/s00394-016-1353-3 *
DIPUN NIRMAL PERERA ET AL: "Factors affecting iron absorption and the role of fortification in enhancing iron levels", NUTRITION BULLETIN, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 48, no. 4, 15 November 2023 (2023-11-15), pages 442 - 457, XP072537156, ISSN: 1471-9827, DOI: 10.1111/NBU.12643 *
GLAHN, R.P. ET AL.: "Caco-2 cell ferritin formation predicts non-radiolabeled food iron availability in an in vitro digestion/Caco-2 cell culture model.", J. NUTR., vol. 128, 1998, pages 1555 - 1561
RAZA, IQBALULLAH, KHANIMRAN: "Enzymatic conversion of milk lactose to prebiotic galactooligosaccharides to produce low lactose yogurt", J FOOD PROCESS PRESERV., vol. 42, 2018, pages e13586, Retrieved from the Internet <URL:https://doi.org/10.1111/jfpp.13586>
SCHEUCHZER PORNPIMOL ET AL: "Iron Absorption from an Iron-Fortified Follow-Up Formula with and without the Addition of a Synbiotic or a Human-Identical Milk Oligosaccharide: A Randomized Crossover Stable Isotope Study in Young Thai Children", THE JOURNAL OF NUTRITION, vol. 154, no. 10, October 2024 (2024-10-01), US, pages 2988 - 2998, XP093354668, ISSN: 0022-3166, DOI: 10.1016/j.tjnut.2024.08.016 *
TAKASUGI SATOSHI ET AL: "A Combination of a Dairy Product Fermented by Lactobacilli and Galactooligosaccharides Shows Additive Effects on Mineral Balances in Growing Rats with Hypochlorhydria Induced by a Proton Pump Inhibitor", BIOLOGICAL TRACE ELEMENT RESEARCH, HUMANA PRESS, CLIFTON, NJ, US, vol. 153, no. 1, 4 May 2013 (2013-05-04), pages 309 - 318, XP035319089, ISSN: 0163-4984, [retrieved on 20130504], DOI: 10.1007/S12011-013-9681-0 *

Similar Documents

Publication Publication Date Title
RU2356247C2 (ru) Комбинации и композиции, содержащие жирные кислоты и аминокислоты, их применение для предупреждения, замедления прогрессирования или лечения диабета и связанных с диабетом заболеваний и состояний, способ снижения веса тела млекопитающего, набор
JP6116913B2 (ja) 栄養組成物
US20040253227A1 (en) Perioperative multivitamin protein beverage and additive for use in preparing an individual for fast surgical recovery
US20190335796A1 (en) Optimized nutrient food
US20060099277A1 (en) Protein and fruit juice product
AU2004296647B2 (en) Enteropathy ameliorating composition
RU2391864C2 (ru) Способ коррекции диеты группы пациентов
EP2627196B1 (fr) Smoothie à base de produits laitiers pour stimuler la croissance chez des enfants
AU2016269605B2 (en) Compositions comprising cinnamaldehyde and zinc and methods of using such compositions
RU2525338C2 (ru) Инстантный функциональный пищевой продукт
AU2024260161A1 (en) Compositions and methods for improving brain health
WO2026093449A1 (fr) Compositions et procédés utilisant un galacto-oligosaccharide pour augmenter l&#39;absorption de zinc
WO2026093450A1 (fr) Compositions et procédés utilisant un galacto-oligosaccharide pour augmenter l&#39;absorption de calcium par amélioration de sa solubilité
JP5006577B2 (ja) 生活習慣病改善剤
KR100628539B1 (ko) 혈압상승 억제 및 혈압강하 효과가 있는 요구르트 조성물
JP4435882B2 (ja) アルコール吸収抑制組成物
TW202034944A (zh) 一種大豆分離蛋白用於製備預防或治療骨鬆合併肌少症、提升身體機能及降低運動後疲勞之組合物的用途。
JP2005239686A (ja) 脂肪燃焼促進組成物及び該組成物を含有する食品又は医薬品
WO2026093462A1 (fr) Composition à base de lait à faible teneur en lactose et à faible teneur en sucre comprenant des galactooligosaccharides destinés à être utilisés pour améliorer la santé musculaire chez un nourrisson, un jeune enfant ou un enfant
WO2026052695A1 (fr) Compositions et procédés d&#39;amélioration de la santé gastrointestinale
Porter Dietary Treatment of Gastrointestinal Diseases
WO2026093460A1 (fr) Compositions à base de lait comprenant un gos et procédés utilisant ces compositions pour améliorer la santé osseuse chez un nourrisson, un jeune enfant ou un enfant
WO2026052725A1 (fr) Ingrédient alimentaire et produits de type boisson
Imma et al. CALCIUM FROM A CALCIUM-RICH MINERAL WATER: SUPPLEMENTATION AND BIOAVAILABILITY
KR101477765B1 (ko) 비만의 예방 및 관리에 유용한 식이조성물